BD (NYSE: BDX) announced today that the FDA granted 510(k) clearance for its EnCore EnCompass breast biopsy and tissue ...

Becton, Dickinson and Co. will invest more than $110M to expand a Nebraska syringe facility, add 120 jobs and support ...

A major American medical device manufacturer is investing $110 million to expand production in Nebraska as part of an effort ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host its virtual 2026 Annual Meeting of Shareholders (the "Annual Meeting") on ...

The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

Navigate Commercial Finance, the Birmingham-based SME finance broker, is pleased to announce the appointment of Cormac Parize ...

Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...

BD (Becton, Dickinson and Company) has announced a $110m investment to expand its production of prefillable syringes in the ...

Perkins&Will, Skidmore, Owings & Merrill, Gensler, Stantec, LS3P Associates, HOK, NELSON Worldwide, DLR Group, NORR, and ...

Turner Construction, Hensel Phelps, JE Dunn Construction, Walsh Group, Clark Group, Caddell Construction, Okland Construction ...

The FDA clears Becton Dickinson's EnCor EnCompass breast biopsy system, with a U.S. launch planned for early 2026.